We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current M1CK34 market cap is 117.39B. The company's latest EPS is USD 23.0923 and P/E is 24.52.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 74.48B | 77.22B | 80.9B | 76.35B | 79.28B |
| Operating Income | 1.13B | 951M | 614M | 1.22B | 1.03B |
| Net Income | 958M | 664M | 589M | 791M | 915M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 231.05B | 238.23B | 263.97B | 276.72B | 308.95B |
| Operating Income | 1.38B | -4.98B | 2.18B | 4.39B | 3.91B |
| Net Income | 900M | -4.54B | 1.11B | 3.56B | 3B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 64.1B | 66.09B | 66.51B | 67.44B | 71.67B |
| Total Liabilities | 65.34B | 67.56B | 68.19B | 69.04B | 73.05B |
| Total Equity | -1.24B | -1.46B | -1.68B | -1.6B | -1.38B |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 61.25B | 65.02B | 63.3B | 62.32B | 67.44B |
| Total Liabilities | 54.54B | 63.57B | 65.09B | 63.81B | 69.04B |
| Total Equity | 5.31B | 175M | -1.79B | -1.49B | -1.6B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.05B | -87M | 167M | 4.31B | -1.38B |
| Investing | -149M | -315M | -495M | -1.07B | -87M |
| Financing | -843M | -1.75B | -2.37B | -3.34B | -809M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 4.37B | 4.54B | 4.43B | 5.16B | 4.31B |
| Investing | -579M | -415M | -89M | -542M | -1.07B |
| Financing | -2.73B | -1.69B | -6.32B | -4.37B | -3.34B |
| Market Cap | 117.39B |
| Price to Earnings Ratio | 24.52 |
| Price to Sales Ratio | 0.24 |
| Price to Cash Ratio | 16.06 |
| Price to Book Ratio | -46.03 |
| Dividend Yield | 0.32% |
| Shares Outstanding | 130M |
| Average Volume (1 week) | 1 |
| Average Volume (1 Month) | 221 |
| 52 Week Change | 53.83% |
| 52 Week High | 942.82 |
| 52 Week Low | 587.03 |
| Spread (Intraday) | 74.8 (8.56%) |
| Company Name | McKesson Corp |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.mckesson.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
